12.5.3 C4 Right of Reversion. Upon termination of the Agreement by C4 pursuant to Section12.2.2 (By C4) or Section12.4 (Termination for Convenience), in whole or with respect to one or more Development Candidates, Products, or Collaboration Targets: Biogen will assign to C4 Biogens rights, title, and interests in and to any Product-Specific Patent Rights that (a)were assigned to Biogen pursuant to Section10.2.2(a) (Assignment) and (b)Cover such terminated Development Candidates, Products, or Collaboration Targets.
09/10/2020 (C4 Therapeutics, Inc.)
SourceBuild document automations that allow you, your staff, and your clients to auto-populate contract templates.
“I've found it very easy to use. It allows me to work quickly, get something straight from my head and out into the public.”
Partner, Siskind Susser PC
2500 Executive Parkway
Suite 300
Lehi, Utah 84043
(866) 638-3627
Level 11, 1 Margaret Street
Sydney NSW 2000
Australia
+61 2 8310 4319
8th Floor South
Reading Bridge House
George Street
Reading RG1 8LS
+44 20 3129 9324
© NetDocuments Software, Inc.